[Tree] Immunome, Inc.'s Q1 2025 earnings and Invivyd's new COVID-19 PrEP therapy, ME Therapeutics Holdings Inc.'s ringing of the CSE opening bell

Version 0.18 (2024-04-15 15:23:58.189000)

updates: ME Therapeutics Holdings Inc. rings opening bell on Canadian Securities Exchange

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.17 (2024-04-04 22:24:33.538000)

updates: Wedbush analyst predicts Immunome, Inc.'s Q1 2025 earnings Invivyd announces availability of PEMGARDA for COVID-19 PrEP therapy in the U.S.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.16 (2024-04-03 10:59:05.335000)

updates: Includes Wedbush analyst's Q1 2025 earnings estimate for Immunome, Inc.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.15 (2024-04-03 09:24:43.119000)

updates: JMP Securities rates Werewolf Therapeutics stock Outperform

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.14 (2024-03-27 22:28:24.011000)

updates: Immunovant receives Outperform rating from Oppenheimer

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.13 (2024-03-22 20:24:09.529000)

updates: Invivyd's monoclonal antibody receives FDA emergency use authorization

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.12 (2024-03-19 20:24:14.917000)

updates: Madrigal Pharmaceuticals receives price target increase from Evercore ISI

  • ➔
  • ➔
  • ➔
Version 0.11 (2024-03-19 16:24:14.161000)

updates: A new story about Genprex's registered direct offering

  • ➔
  • ➔
Version 0.11 (2024-03-19 16:24:14.161000)

updates: A new story about Genprex's registered direct offering

  • ➔
  • ➔
Version 0.1 (2024-03-19 15:22:47.131000)

updates: Fennec Pharmaceuticals out-licenses EU commercial rights for Pedmarqsi to Norgine

  • ➔
Version 0.09 (2024-03-02 20:23:26.731000)

updates: Add information about Phathom Pharmaceuticals earnings announcement

  • ➔
  • ➔
Version 0.08 (2024-03-02 16:25:25.656000)

updates: Includes details about the trading volume and upgrade for Tarsus Pharmaceuticals

  • ➔
Version 0.07 (2024-03-02 06:24:45.350000)

updates: Short interest in DENTSPLY SIRONA Inc. increases

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-02-23 05:42:53.190000)

updates: Guardant Health's Q4 2024 Earnings Call reveals achievements and goals in cancer diagnostics and treatment

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-02-20 23:26:08.008000)

updates: Aquestive Therapeutics stock performance

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-02-20 23:25:12.523000)

updates: Includes Q4 earnings report for Select Water Solutions, Inc.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2024-02-16 15:50:53.672000)

updates: Add information about T2 Biosystems' earnings call and growth strategy

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2024-02-02 23:49:08.017000)

updates: Addition of Takeda Pharmaceutical Company's earnings report

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-11-11 18:28:17.347000)

updates: Combined two stories about dental industry earnings

  • ➔
  • ➔
  • ➔
Version 0.0 (2023-11-06 16:37:50.566000)

updates:

  • ➔
  • ➔